Influenza, an acute febrile disease of the respiratory system, is caused by an enveloped RNA virus where types A and B cause disease in humans. The disease, which occurs in yearly epidemics (seasonal), and unpredictable pandemics, exerts enormous global burden in terms of mortality, morbidity and economic cost. Yearly vaccination is the mainstay of protection against the constantly changing influenza virus. Currently, a number of influenza vaccines are available and given according to national recommendations to an increasing percentage of the population with a focus on protecting the most vulnerable such as the very young, very old and immunocompromised. Vaccines are mainly of the trivalent inactivated (TIV) format produced by older technology in egg-based production systems. While effective, they have limitations being addressed by manufacturers with cell-based production systems, adjuvantation or alternative delivery systems. However, in the longer term, a more desirable goal is to produce a "universal vaccine" that can protect against all types of influenza viruses (season and pandemic) with lasting protection.
This MarketVIEW product is a comprehensive value ($ 000s) and volume (doses) forecast indicating the commercial potential of new universal influenza vaccines across the major Western markets to 2035 in all current population segments. The model explores the impact of alternative uptake scenarios (LO/HI) and the value of universal antigens as part of seperate new products or adjuncts to existing vaccines. In an accompanying Executive presentation, discussion is included with regard to current competitor approaches, target product profile (TPP) analysis and other major commercial assumptions e.g. pricing, boosting, strain coverage and market dynamics. Early indications of expected revenues per competitor, both POS and NOS-POS adjusted are also indicated.
*Prices quotes are for 1 region license only. Regions are North America, or EU or ROW.
For UK orders VAT will be added at 17.5%.
Please review the TERMS and CONDITIONS of purchase.
